<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03879044</url>
  </required_header>
  <id_info>
    <org_study_id>2018H0139</org_study_id>
    <nct_id>NCT03879044</nct_id>
  </id_info>
  <brief_title>Transcranial Direct Current Stimulation Therapy for Sleepiness Related to Shift Work Disorder (tDCS-SWORD)</brief_title>
  <acronym>tDCS-SWORD</acronym>
  <official_title>Transcranial Direct Current Stimulation Therapy for Sleepiness Related to Shift Work Disorder (tDCS-SWORD)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ohio State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ohio State University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      1. To determine the effects of tDCS on subjective measures of sleepiness in night-shift&#xD;
           workers with shift work disorder.&#xD;
&#xD;
        2. To determine the effects of transcranial direct current stimulation (tDCS) on vigilance&#xD;
           in night-shift workers with shift work disorder.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a preliminary single-arm study. The study will last up to 6 weeks including the&#xD;
      screening period. Subjects will receive active tDCS for 30 minutes before their scheduled&#xD;
      work hours at least 3x/week for two consecutive weeks.&#xD;
&#xD;
      Outcome measures will include: psychomotor vigilance test (PVT) and the Karolinska Sleepiness&#xD;
      Scale (KSS)25,26 which will be obtained during the shift work.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Funding stopped&#xD;
  </why_stopped>
  <start_date type="Actual">March 20, 2019</start_date>
  <completion_date type="Actual">June 20, 2020</completion_date>
  <primary_completion_date type="Actual">June 20, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>This is a preliminary single-arm study. The study will last up to 6 weeks including the screening period. Subjects will receive active tDCS for 30 minutes before their scheduled work hours at least 3x/week for two consecutive weeks.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Psychomotor Vigilance Test</measure>
    <time_frame>3 minutes</time_frame>
    <description>Objective measure of sleepiness. Scale ranges between each individual, with the reciprocal of the reaction time being reported.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Karolinska Sleepiness Scale</measure>
    <time_frame>5 minutes</time_frame>
    <description>Subjective measure of sleepiness. Scale ranges from 1-9, with total score being reported.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Epworth Sleepiness Scale</measure>
    <time_frame>5 minutes</time_frame>
    <description>Subjective measure of sleepiness. The scale ranges from 0-24, with the total score being reported.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Shift-Work Sleep Disorder</condition>
  <arm_group>
    <arm_group_label>Transcranial Direct Current Stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Active tDCS for 30 minutes before their scheduled work hours at least 3x/week for two consecutive weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcranial Direct Current Stimulation</intervention_name>
    <description>tDCS is a form of noninvasive, painless, brain stimulation that uses a mild direct electrical current passed between electrodes on the scalp to modify neuronal membrane resting potential in a polarity dependent manner, elevating or lowering neuron excitability in a region.</description>
    <arm_group_label>Transcranial Direct Current Stimulation</arm_group_label>
    <other_name>tDCS</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age 18-65 years&#xD;
&#xD;
          -  works 5 or more night shifts per month (each shift lasting at least 10 hours, with â‰¥6&#xD;
             hours worked between 10 pm and 8 am) with plans to maintain this schedule for the&#xD;
             duration of the 3-week trial&#xD;
&#xD;
          -  meets the criteria for Shift Work Disorder according to the International&#xD;
             Classification of Sleep Disorders24 and evaluation of a sleep medicine provider&#xD;
             (physician or nurse practitioner) during a screening evaluation:&#xD;
&#xD;
               1. affirmative answers to Do you experience excessive sleepiness? (yes/no); &quot;Do you&#xD;
                  experience difficulties with falling asleep during opportunities for sleep?&#xD;
                  (yes/no); &quot;Is the sleep or sleepiness problem related to a work schedule where&#xD;
                  you have to work when you would normally sleep? (yes/no)&quot;; and &quot;Has this sleep or&#xD;
                  sleepiness problem related to your work schedule persisted for at least three&#xD;
                  months? (yes/no)&#xD;
&#xD;
               2. based on the evaluation of the sleep medicine provider, the sleep and/or wake&#xD;
                  disturbance are not better explained by another current sleep disorder, medical&#xD;
                  or neurologic disorder, mental disorder, medication use, poor sleep hygiene, or&#xD;
                  substance abuse disorder.&#xD;
&#xD;
          -  Stable medication dosage over previous 4 weeks.&#xD;
&#xD;
          -  Able to understand English and give a written informed consent document.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Currently taking stimulant medications such as Modafinil, Armodafinil,&#xD;
             Methylphenidate, or Dextroamphetamine.&#xD;
&#xD;
          -  History of automobile accident due to falling asleep while driving&#xD;
&#xD;
          -  Inability to understand or read English&#xD;
&#xD;
          -  Self-reported Substance abuse (current)&#xD;
&#xD;
          -  Excessive alcohol consumption defined as:&#xD;
&#xD;
          -  More than 3 glasses of wine a day&#xD;
&#xD;
          -  More than 3 beers a day&#xD;
&#xD;
          -  More than 60 mL of hard liquor a day&#xD;
&#xD;
          -  Presence of cardiac pacemaker or automatic implantable cardioverter-defibrillator&#xD;
             (AICD).&#xD;
&#xD;
          -  Pregnancy, lactation (will be screened with urine pregnancy test)&#xD;
&#xD;
          -  Non-removable metal or tattoos around head&#xD;
&#xD;
          -  Use of implantable birth control device such as Implanon&#xD;
&#xD;
          -  History of frequent severe headaches&#xD;
&#xD;
          -  Unstable coronary artery disease&#xD;
&#xD;
          -  Uncontrolled Seizure disorder&#xD;
&#xD;
          -  Uncontrolled hypertension&#xD;
&#xD;
          -  Any other clinically significant condition that, in the opinion of the Investigator,&#xD;
             might put the subject at risk of harm during the study or might adversely affect the&#xD;
             interpretation of the study data.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ulysses Magalang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Ohio State University Wexner Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>March 12, 2019</study_first_submitted>
  <study_first_submitted_qc>March 15, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 18, 2019</study_first_posted>
  <results_first_submitted>July 28, 2021</results_first_submitted>
  <results_first_submitted_qc>October 22, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">October 25, 2021</results_first_posted>
  <last_update_submitted>October 22, 2021</last_update_submitted>
  <last_update_submitted_qc>October 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ohio State University</investigator_affiliation>
    <investigator_full_name>Ulysses Magalang MD</investigator_full_name>
    <investigator_title>Professor of Medicine and Neuroscience Director, Sleep Medicine Program</investigator_title>
  </responsible_party>
  <keyword>Transcranial Direct Current Stimulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Wake Disorders</mesh_term>
    <mesh_term>Sleep Disorders, Circadian Rhythm</mesh_term>
    <mesh_term>Sleepiness</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>July 7, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/44/NCT03879044/Prot_SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>July 9, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/44/NCT03879044/ICF_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Transcranial Direct Current Stimulation</title>
          <description>Active tDCS for 30 minutes before their scheduled work hours at least 3x/week for two consecutive weeks.&#xD;
Transcranial Direct Current Stimulation: tDCS is a form of noninvasive, painless, brain stimulation that uses a mild direct electrical current passed between electrodes on the scalp to modify neuronal membrane resting potential in a polarity dependent manner, elevating or lowering neuron excitability in a region.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Transcranial Direct Current Stimulation</title>
          <description>Active tDCS for 30 minutes before their scheduled work hours at least 3x/week for two consecutive weeks.&#xD;
Transcranial Direct Current Stimulation: tDCS is a form of noninvasive, painless, brain stimulation that uses a mild direct electrical current passed between electrodes on the scalp to modify neuronal membrane resting potential in a polarity dependent manner, elevating or lowering neuron excitability in a region.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="26"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <population>We analyzed data of participants who fully complete baseline questionnaires</population>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31.33" spread="7.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <population>We analyzed data of participants who fully complete baseline questionnaires</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <population>We analyzed data of participants who fully complete baseline questionnaires</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <population>We analyzed data of participants who fully complete baseline questionnaires</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <population>We analyzed data of participants who fully complete baseline questionnaires</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Psychomotor Vigilance Test</title>
        <description>Objective measure of sleepiness. Scale ranges between each individual, with the reciprocal of the reaction time being reported.</description>
        <time_frame>3 minutes</time_frame>
        <population>Objective sleepiness based on Psychomotor Vigilance Test could not be analyzed and reported in the table data as we were unable to collect data from enrolled patients.</population>
        <group_list>
          <group group_id="O1">
            <title>Transcranial Direct Current Stimulation</title>
            <description>Active tDCS for 30 minutes before their scheduled work hours at least 3x/week for two consecutive weeks.&#xD;
Transcranial Direct Current Stimulation: tDCS is a form of noninvasive, painless, brain stimulation that uses a mild direct electrical current passed between electrodes on the scalp to modify neuronal membrane resting potential in a polarity dependent manner, elevating or lowering neuron excitability in a region.</description>
          </group>
        </group_list>
        <measure>
          <title>Psychomotor Vigilance Test</title>
          <description>Objective measure of sleepiness. Scale ranges between each individual, with the reciprocal of the reaction time being reported.</description>
          <population>Objective sleepiness based on Psychomotor Vigilance Test could not be analyzed and reported in the table data as we were unable to collect data from enrolled patients.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Karolinska Sleepiness Scale</title>
        <description>Subjective measure of sleepiness. Scale ranges from 1-9, with total score being reported.</description>
        <time_frame>5 minutes</time_frame>
        <population>Subjective sleepiness based on Karolinska Sleepiness Scale instrument could not be analyzed and reported in the table data as we were unable to collect data from enrolled patients.</population>
        <group_list>
          <group group_id="O1">
            <title>Transcranial Direct Current Stimulation</title>
            <description>Active tDCS for 30 minutes before their scheduled work hours at least 3x/week for two consecutive weeks.&#xD;
Transcranial Direct Current Stimulation: tDCS is a form of noninvasive, painless, brain stimulation that uses a mild direct electrical current passed between electrodes on the scalp to modify neuronal membrane resting potential in a polarity dependent manner, elevating or lowering neuron excitability in a region.</description>
          </group>
        </group_list>
        <measure>
          <title>Karolinska Sleepiness Scale</title>
          <description>Subjective measure of sleepiness. Scale ranges from 1-9, with total score being reported.</description>
          <population>Subjective sleepiness based on Karolinska Sleepiness Scale instrument could not be analyzed and reported in the table data as we were unable to collect data from enrolled patients.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Epworth Sleepiness Scale</title>
        <description>Subjective measure of sleepiness. The scale ranges from 0-24, with the total score being reported.</description>
        <time_frame>5 minutes</time_frame>
        <population>Subjective sleepiness based on Epworth Sleepiness Scale instrument could not be analyzed and reported in the table data as we were unable to collect data from enrolled patients.</population>
        <group_list>
          <group group_id="O1">
            <title>Transcranial Direct Current Stimulation</title>
            <description>Active tDCS for 30 minutes before their scheduled work hours at least 3x/week for two consecutive weeks.&#xD;
Transcranial Direct Current Stimulation: tDCS is a form of noninvasive, painless, brain stimulation that uses a mild direct electrical current passed between electrodes on the scalp to modify neuronal membrane resting potential in a polarity dependent manner, elevating or lowering neuron excitability in a region.</description>
          </group>
        </group_list>
        <measure>
          <title>Epworth Sleepiness Scale</title>
          <description>Subjective measure of sleepiness. The scale ranges from 0-24, with the total score being reported.</description>
          <population>Subjective sleepiness based on Epworth Sleepiness Scale instrument could not be analyzed and reported in the table data as we were unable to collect data from enrolled patients.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events were assessed through study completion (6 weeks for each participant).</time_frame>
      <desc>No adverse events were observed or reported during the study.</desc>
      <group_list>
        <group group_id="E1">
          <title>Transcranial Direct Current Stimulation</title>
          <description>Active tDCS for 30 minutes before their scheduled work hours at least 3x/week for two consecutive weeks.&#xD;
Transcranial Direct Current Stimulation: tDCS is a form of noninvasive, painless, brain stimulation that uses a mild direct electrical current passed between electrodes on the scalp to modify neuronal membrane resting potential in a polarity dependent manner, elevating or lowering neuron excitability in a region.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Outcome measurements and adverse events were not analyzed and reported as the study was terminated due to funding stopped</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Ulysses Magalang</name_or_title>
      <organization>The Ohio State University Wexner Medical Center</organization>
      <phone>614-292- 4307</phone>
      <email>Ulysses.Magalang@osumc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

